Rapid Micro Biosystems (RPID) Osake Kurssi
Rapid Micro Biosystems Kurssi
Liikevaihto on kasvanut 5,0 % vuodessa viimeisten 15 vuoden aikana 33,59 M USD:een. Rapid Micro Biosystemsn nettomarginaali on nyt −140,3 %, noussut −316,5 %:sta muutama vuosi sitten.
Rapid Micro Biosystems osakekurssi
Rapid Micro Biosystems liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Rapid Micro Biosystems -osakkeesta
The business model of Rapid Micro Biosystems Inc is centered around providing innovative solutions for microbial quality control in the pharmaceutical and healthcare industries. The company offers automated microbial detection systems that enable faster and more efficient testing of samples, allowing pharmaceutical companies to streamline their processes and minimize the risk of contamination. Rapid Micro Biosystems Inc's technology helps customers improve product quality, reduce time-to-results, and increase operational efficiency. With its cutting-edge products and services, the company aims to revolutionize microbial testing and support the production of safe and high-quality pharmaceuticals.
Rapid Micro Biosystems Inc is primarily active in the pharmaceutical, biotechnology, and healthcare industries.
The main competitors of Rapid Micro Biosystems Inc in the market include Thermo Fisher Scientific Inc., BioMérieux SA, and Beckman Coulter Inc.
Rapid Micro Biosystems Inc is a renowned company specialized in innovative microbial detection and enumeration systems. Founded in 2006, Rapid Micro Biosystems has a rich history of developing cutting-edge technologies for the pharmaceutical, personal care, and clinical industries. The company focuses on automating and streamlining microbial quality testing processes, offering faster and more accurate results. With a wide range of solutions, including Growth Direct™, Rapid Micro Biosystems aids customers in improving their manufacturing efficiency, ensuring product safety, and minimizing risks associated with microbial contamination. Rapid Micro Biosystems Inc continues to revolutionize microbial detection, providing reliable and advanced solutions to various industries worldwide.
Rapid Micro Biosystems Inc has achieved several significant milestones. Firstly, the company successfully developed the Growth Direct™ System, a cutting-edge automated microbial detection platform used in pharmaceutical manufacturing. Additionally, Rapid Micro Biosystems Inc received strategic funding from top investors, allowing them to expand their operations and commercialize their products globally. They also gained regulatory approvals for their innovative technology, further establishing themselves as a leading player in the industry. Additionally, Rapid Micro Biosystems Inc has secured partnerships and collaborations with prominent pharmaceutical companies, strengthening their market position and facilitating growth. With these achievements, Rapid Micro Biosystems Inc continues to revolutionize microbial testing and make significant advancements in the field.
Rapid Micro Biosystems Inc is primarily present in the United States, alongside multiple international regions.
Rapid Micro Biosystems Inc represents values of innovation, efficiency, and reliability in the field of microbiology. With a strong corporate philosophy focused on advancing automation and streamlining processes, Rapid Micro Biosystems aims to transform the way microbiological testing is conducted. Their cutting-edge technologies and solutions enable faster and more accurate detection of microbial contaminants, helping industries ensure the safety and quality of their products. Through their commitment to providing reliable and efficient microbiology systems, Rapid Micro Biosystems Inc contributes to improved productivity, reduced costs, and enhanced product quality across various industries.
10 analyytikkoa arvioi tällä hetkellä Rapid Micro Biosystems-osaketta: 9 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Rapid Micro Biosystems-yhtiöltä 39,28 M USD liikevaihtoa ja −0,94 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Rapid Micro Biosystems-osake noteerataan hintaan 0,79 EUR (0,88 USD).
Rapid Micro Biosystems-osake (RPID) on listattuna 1 pörssissä, muun muassa: NASDAQ (RPID).
Rapid Micro Biosystems Inc. specializes in the manufacturing of automated solutions for microbiological testing and production controls. The company operates in the biotechnology industry and offers a variety of products and services. One of the main products is the Growth DirectTM, an automated system for identifying, quantifying, and monitoring microorganisms in biopharmaceutical production processes. It is used by customers in the pharmaceutical and biotechnology industries to optimize production processes and perform quality controls. Another core product is the Growth DirectTM System for environmental monitoring. It provides a fast, easy, and reliable way to perform environmental controls throughout the manufacturing process. The company also offers services such as installation, training, maintenance, and support for its systems. Rapid Micro Biosystems has a strong presence in the global market and works with customers in Asia, Europe, and North America. Overall, the company focuses on developing solutions for managing microbiological tests and process monitoring in the biotechnology and pharmaceutical industries, aiming to provide customers with more efficient process optimization and error detection.
odotettu liikevaihto Rapid Micro Biosystems on 39,28 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Rapid Micro Biosystems on −41,77 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Rapid Micro Biosystems:n hinta-voitto-suhde (P/E) on tällä hetkellä −0,94. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Rapid Micro Biosystems-osakkeen arvostusta.
Rapid Micro Biosystems:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,00. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Rapid Micro Biosystems-osakkeen arvostuskennuslukuna.
Rapid Micro Biosystems:n Eulpool-laatuscore on 3/10.
Rapid Micro Biosystems:n ISIN on US75340L1044. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Rapid Micro Biosystems:n ticker on RPID. Tämä pörssinoteeraus käytetään Rapid Micro Biosystems-osakkeiden kauppaan pörssissä.
Rapid Micro Biosystems osake
Rapid Micro Biosystems vertaisryhmä
Rapid Micro Biosystems Ticker
Rapid Micro Biosystems FIGI
Kaikki tunnusluvut ja syvällinen analyysi Rapid Micro Biosystems:sta
Meidän osakeanalyysimme Rapid Micro Biosystems-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Rapid Micro Biosystems:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: